Selected health and lifestyle factors, cytosine-adenine-guanine status, and phenoconversion in Huntington's disease.

Autor: Tanner C; Parkinson's Disease Research, Education and Clinical Center, Neurology, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA.; Department of Neurology, University of California-San Francisco, San Francisco, California, USA., Marder K; Departments of Neurology and Psychiatry, Taub Institute for Research on the Aging Brain, Gertrude H. Sergievsky Center, Columbia University College of Physicians and Surgeons, New York, New York, USA., Eberly S; Department of Biostatistics and Computational Biology, University of Rochester, New York, New York, USA., Biglan K; Eli Lilly and Company, Indianapolis, Indiana, USA.; Department of Neurology, University of Rochester, New York, New York, USA., Oakes D; Department of Biostatistics and Computational Biology, University of Rochester, New York, New York, USA., Shoulson I; Department of Neurology, Georgetown University, Washington, D.C., USA.

Publikováno v: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2018 Mar; Vol. 33 (3), pp. 472-478. Date of Electronic Publication: 2018 Jan 03.